Every year, 4,000 Australians lose their lives to dust diseases. As long as mesothelioma, silicosis and asbestos-related diseases threaten public health, we will be relentless in our mission to improve patient outcomes and leave a positive impact on people’s lives. Our research institute may be small, but with some of the best research minds in the country and global health leaders behind us, our ambition is large. Our passion and agility are backed by our status as a WHO Collaborating Centre for the Elimination of Asbestos Related Diseases. In the lab, we discover improved prevention methods, diagnosis, and treatment. Our pioneering molecular and biological techniques are scrutinised on blood and tissue specimens stored in the ADRI Biobank. Committed to making a genuine difference, we convert promising therapeutic approaches into clinical practice, provide patient support, and drive advocacy and community awareness. People are the heart of what we do and we will not rest until we find a cure for mesothelioma and address dust and asbestos-related diseases head on.